Featured Products

Eppendorf and the journal Science are now accepting applications for the 2023 Eppendorf & Science Prize for Neurobiology.

Bruker Corporation has announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle MultiscopesTM for simultaneous multi-region, optical functional neuroimaging.

Bruker Corporation has announced the acquisition of Inscopix, Inc., a neuroscience pioneer and marketer of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging.

Blackrock Neurotech revealed its next-generation neural interface, Neuralace™, at Society for Neuroscience 2022.

Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis platform.

The American scientist Ann Kennedy, PhD, assistant professor at Northwestern University, Chicago, USA has won the 2022 Eppendorf & Science Prize for Neurobiology for her work on the neural population dynamics that generate and maintain our emotions and behavioral drives.

Cell coding company bit.bio has announced an expansion to its product portfolio to enable scientists to study neurodegenerative diseases in a human context.

ONWARD Medical N.V., the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that the Up-LIFT pivotal study evaluating ARC-EX Therapy achieved its primary effectiveness endpoint of improvement in upper extremity strength and function.

Ziath announce the launch of the Mohawk 48 tube selector and picker. Designed to select and pick wide, heavy, or tall tubes - this new system is perfect for retrieving individual whole tissue samples from storage.

VectorBuilder Inc. has announced that its partnership with cell and gene therapy company Lantu Biopharma has led to the first human trial of an innovative gene therapy drug candidate for Menkes disease.